Michael E. Prevoznik - 18 Feb 2026 Form 4 Insider Report for QUEST DIAGNOSTICS INC (DGX)

Source evidence 5 source fields
Form type
4
Accepted by SEC
20 Feb 2026, 17:12:09 UTC
Previous filing
30 Sep 2025
Next filing
04 Mar 2026
SEC filing
View on sec.gov
Reporting owner 1 detail
Reporting owner signature
Sean D. Mersten, Attorney in Fact for Michael E. Prevoznik

Key filing fact

Michael E. Prevoznik filed Form 4 for QUEST DIAGNOSTICS INC (DGX) on 20 Feb 2026.

Key facts

  • This page summarizes Michael E. Prevoznik's Form 4 filing for QUEST DIAGNOSTICS INC (DGX).
  • 5 reported transactions and 1 derivative row are listed below.
  • Accepted by SEC: 20 Feb 2026, 17:12.

Change

  • Previous filing in this sequence was filed on 30 Sep 2025.
  • Current net transaction value: -$362,605.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

See Original Filing

Reporting Owners (1)

CIK 0001222679 Primary reporting owner

PREVOZNIK MICHAEL E

Relationship
SVP & General Counsel
Address
500 PLAZA DRIVE, SECAUCUS
Signature
Sean D. Mersten, Attorney in Fact for Michael E. Prevoznik
Signature date
20 Feb 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

DGX transaction

Common Stock

Award

Transaction value
$0
Shares
+2,013
Change %
+5.3%
Price
$0.000000
Shares after
40,130
Date
18 Feb 2026
Ownership
Direct
Footnotes
F1
DGX transaction

Common Stock

Tax liability

Transaction value
$63,213
Shares
-301
Change %
-0.75%
Price
$210.01
Shares after
39,829
Date
18 Feb 2026
Ownership
Direct
Footnotes
F2
DGX transaction

Common Stock

Tax liability

Transaction value
$71,826
Shares
-347
Change %
-0.87%
Price
$206.99
Shares after
39,482
Date
18 Feb 2026
Ownership
Direct
Footnotes
F2
DGX transaction

Common Stock

Sale

Transaction value
$227,566
Shares
-1,111
Change %
-2.8%
Price
$204.83
Shares after
38,371
Date
19 Feb 2026
Ownership
Direct
Footnotes
F3
DGX holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
5,738
Date
18 Feb 2026
Ownership
401(k)/SDCP
Footnotes
F4

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

DGX transaction Derivative

Non-Qualifed Stock Option (right to buy)

Award

Transaction value
$0
Shares
+9,289
Change %
Price
$0.000000
Shares after
9,289
Date
18 Feb 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
9,289
Exercise price
$204.96
Footnotes
F5
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Rule 10b5-1 trading plan

These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.

Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).

Explanation of responses 5 footnotes

Footnote F1

Represents an award of restricted stock units.

Footnote F2

Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the vesting of restricted stock units.

Footnote F3

This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person.

Footnote F4

These underlying shares were acquired on a periodic basis by the trustee of the Company's tax qualified Profit Sharing (401(k)) and/or Supplemental Deferred Compensation Plan. The information was obtained from the plan administrator as of a current date. The number of shares is based on the account balance of the Company stock fund under each Plan (which includes some money market instruments) divided by the market price of the Company's stock as of that date.

Footnote F5

The options vest in three equal annual installments beginning on the first annual anniversary of the grant date.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .